CTRI/2015/04/005691尚未招募2 期
CLINICAL EVALUATION OF PUNARNAVA GUGGULU AND RASNA SAPTAKA KASHAYA IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS
CENTRAL COUNCIL FOR RESEARCH IN AYURVDEDIC SCIENCES0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1). Patients of either sex with age between 20 and 60 years
- •2). Presence of any four out of the following seven criteria (according to 1987, revised criteria of American College of Rheumatology)
- •a.Morning stiffness: Stiffness in and around joints lasting one hour before maximal improvement (More than 6 weekâ??s duration).
- •b.Arthritis of three or more joints, at least three joint area, observed by Physician, having pain with soft tissue swelling or joint effusion, not just bony over growth, (more than 6 weeks duration).
- •c.Arthritis of hand joints, at least 1 area in wrist and hand is swollen (more than 6 weeks duration).
- •d. Symmetric arthritis (more than 6 weekâ??s duration).
- •e. Presence of rheumatoid Nodules
- •f. Serum rheumatoid factor- positive
- •g. Typical radiographic changes of arthritis on PA view of hand & wrist radiograph that must include erosions or unequivocal bony decalcification, localized in or adjacent to involved joints.
- •3).Patients willing and able to participate in the study for 14 weeks.
排除标准
- •1. Patients who have developed complications of Rheumatoid Arthritis e.g. deformity of joints / bones, pleura-pericardial disease, or else.
- •2. Patients who are unable to walk without support and / or confined to wheel chair.
- •3. Patients with structural deformity as the complication of RA.
- •4. Patients with poorly controlled Hypertension ( >160/100 mm of Hg)
- •5. Patients with poorly controlled Diabetes Mellitus ({B.S. (F) >126 mg/dl and /or B.S.(2 hr. PP) >200 mg/dl}.
- •6. Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis etc.
- •7. Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholin- ergics, etc. or any other drugs that may have an influence on the outcome of the study.
- •8. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •9. Symptomatic patients with clinical evidence of Heart failure.
- •10.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg /dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
- •11. Alcoholics and/or drug abusers.
- •12. H/o hypersensitivity to any of the trial drugs or their ingredients.
- •13. Pregnant / lactating woman.
- •14. Patients who have completed participation in any other clinical trial during the past six (06) months.
- •15. Any other condition which the Investigator thinks may jeopardize the study.
研究者
相似试验
招募中
不适用
Bloodletting and Raasna Guggulu in Treatment of SciaticaCTRI/2022/06/043416ttarakhand Ayurved University
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulation in the management of arthritis.CTRI/2012/02/002416Department of AYUSH Ministry of Health and Family Welfare Government of India150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Arthritis.CTRI/2012/07/002776Central Council for Research in Ayurvedic Sciences CCRAS150
招募中
2 期
Management of Gout through AyurvedaCTRI/2021/04/033171Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Prostate enlargement.CTRI/2012/04/002586Department of AYUSH Ministry of Health Family Welfare Government of India150